Heterodimerization With 5-HT 2B R Is Indispensable for β 2 AR-Mediated Cardioprotection

Author:

Song Ying1,Xu Chanjuan2,Liu Jianfeng2ORCID,Li Yulong345,Wang Huan1,Shan Dan1,Wainer Irving W.6,Hu Xinli1,Zhang Yan1ORCID,Woo Anthony Yiu-Ho17ORCID,Xiao Rui-Ping1489

Affiliation:

1. State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China (Y.S., D.S., X.H., Y.Z., A.Y.-H.W., R.-P.X.).

2. Cellular Signaling laboratory, International Research Center for Sensory Biology and Technology of MOST, Key Laboratory of Molecular Biophysics of MOE, School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China (C.X., J.L.).

3. State Key Laboratory of Membrane Biology, Peking University School of Life Sciences, Beijing, China (Y.L., H.W.).

4. Peking-Tsinghua Center for Life Sciences, Beijing, China (Y.L., H.W., R.-P.X.).

5. PKU-IDG/McGovern Institute for Brain Research, Beijing, China (Y.L., H.W.).

6. PAZ Pharmaceuticals, Washington, DC (I.W.W.).

7. Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, China (A.Y.-H.W.).

8. Beijing City Key Laboratory of Cardiometabolic Molecular Medicine, Peking University, China (R.-P.X.).

9. PKU-Nanjing Institute of Translational Medicine, China (R.-P.X.).

Abstract

Rationale: The β 2 -adrenoceptor (β 2 -AR), a prototypical GPCR (G protein-coupled receptor), couples to both G s and G i proteins. Stimulation of the β 2 -AR is beneficial to humans and animals with heart failure presumably because it activates the downstream G i -PI3K-Akt cell survival pathway. Cardiac β 2 -AR signaling can be regulated by crosstalk or heterodimerization with other GPCRs, but the physiological and pathophysiological significance of this type of regulation has not been sufficiently demonstrated. Objective: Here, we aim to investigate the potential cardioprotective effect of β 2 -adrenergic stimulation with a subtype-selective agonist, (R,R’)-4-methoxy-1-naphthylfenoterol (MNF), and to decipher the underlying mechanism with a particular emphasis on the role of heterodimerization of β 2 -ARs with another GPCR, 5-hydroxytryptamine receptors 2B (5-HT 2B Rs). Methods and Results: Using pharmacological, genetic and biophysical protein-protein interaction approaches, we studied the cardioprotective effect of the β 2 -agonist, MNF, and explored the underlying mechanism in both in vivo in mice and cultured rodent cardiomyocytes insulted with doxorubicin, hydrogen peroxide (H 2 O 2 ) or ischemia/reperfusion. In doxorubicin (Dox)-treated mice, MNF reduced mortality and body weight loss, while improving cardiac function and cardiomyocyte viability. MNF also alleviated myocardial ischemia/reperfusion injury. In cultured rodent cardiomyocytes, MNF inhibited DNA damage and cell death caused by Dox, H 2 O 2 or hypoxia/reoxygenation. Mechanistically, we found that MNF or another β 2 -agonist zinterol markedly promoted heterodimerization of β 2 -ARs with 5-HT 2B Rs. Upregulation of the heterodimerized 5-HT 2B Rs and β 2 -ARs enhanced β 2 -AR-stimulated G i -Akt signaling and cardioprotection while knockdown or pharmacological inhibition of the 5-HT 2B R attenuated β 2 -AR-stimulated G i signaling and cardioprotection. Conclusions: These data demonstrate that the β 2 -AR-stimulated cardioprotective G i signaling depends on the heterodimerization of β 2 -ARs and 5-HT 2B Rs.

Funder

the National Key R&D Program of China

the National Natural Science Foundation of China

the Beijing Natural Science Foundation

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3